CHANGE IN RATINGS
CA (CA Quote) downgraded at RBC to sector perform from outperform and price target reduced to $20 from $24. Over the next several quarters, RBC believes that investors will shift to more growth names over defensive software stocks, which will likely limit CA's multiple expansion. Covance(CVD Quote)downgraded at Goldman Sachs to Neutral from Buy due to ongoing weakness in preclinical industry demand. See company as well-positioned long-term but also believe current consensus estimates are too high. Price target trimmed to $40 from $43.
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,418.07 | 1,104.06 | 2,198.02 | 34.82 |
Oil *
71.97
|
|
UP
81.02
|
UP
8.12
|
UP
14.29
|
UP
0.59
|
10 Yr
3.48%
SPDR Gold
110.60
|
|
+0.78%
|
+0.74%
|
+0.65%
|
+1.72%
|
Data delayed 20 minutes |














